Diaverum enters Macedonia by acquiring PZU Diamed Macedonia

Lund, Sweden, November 1st, 2018 - Diaverum, one of the leading renal care providers worldwide, announces the acquisition of PZU Diamed Macedonia which operates 9 dialysis centres and cares for more than 670 patients in Macedonia.

Diaverum enters the Macedonian market through the acquisition of PZU Diamed Macedonia. PZU Diamed Macedonia operates 9 dialysis centres since 2014, after being awarded one of two lots in a national public tender. The tender has a duration of 20 years and will last until 2034. 

Macedonia is facing many challenges due to high levels of chronic diseases among the population which put a strain on the healthcare system. 9 percent of the population has diabetes and the prevalence rate of overweight is 54 percent. Among individuals above 18 years, 22 percent suffer from obesity and the prevalence rate of hypertension is 40 percent. Diabetes and hypertension are both major risk factors for the development of kidney disease.

“Diaverum has over 25 years’ experience of successfully treating patients who suffer from renal disease as well as working with preventive care to stop the progression of kidney disease. Both the patients, staff and payers will benefit from Diaverum’s high standards of clinical excellence, world -class training and education programmes and a patient-first approach,” said Boris Zjacic, Senior Vice President and Head of Area East at Diaverum.

“We are delighted that Mrs Vera Ivanova, the former owner of PZU Diamed Macedonia, will stay on as a Country Manager for Diaverum in Macedonia,“ Boris Zjacic continued. “Diaverum brings a lot of experience and international knowledge to the table and I am convinced we can make a real difference for the patients in Macedonia.” 

"It was imperative for me to choose an international company which has a clear patient focus as well as a solid understanding of the local culture. I wanted a company that is able and willing to take what I have created and move it to the next level. This means improving quality standards for the patients as well as providing the employees with more opportunities to grow within the organisation. I also see  an untapped potential in Diaverum partnering with Ministry of Health in the other areas such as transplantation, education and management of other diseases of renal patients,“ said Mrs Vera Ivanova, Country Manager Diaverum Macedonia.

“It is the right momentum to enter Macedonia and this acquisition signals our commitment to the Macedonian market. It is a unique opportunity for us to establish a local presence in Macedonia, as a possible platform for potential further expansion in the Balkan region,” said Dag Andersson, CEO Diaverum.

Christina Waller Sterner
SVP, Chief Commercial Officer
E-mail: christina.sterner@diaverum.com
Mobile ­ +46 767 66 90 67

Diaverum is a global renal care provider with a clear patient focus. As one of the world’s leading renal care providers we stand for excellent medical quality, renal care services and a patient-centred research. Being product-independent also gives us the flexibility to offer individual treatments for the individual needs of our patients and by coordinating our patients’ healthcare needs, we are improving their quality of life. At the same time we are creating value in the healthcare system by optimising the use of healthcare budgets — for the benefit of the patient and the society. Our experience in renal care dates back more than 25 years, when the first dialysis clinic was established, under the former name Gambro Healthcare, defining our Swedish roots. Today 11,000 employees care for more than 33,000 patients in 19 countries in Europe, Latin America, Asia and Middle East. Diaverum has its head office in Lund, Sweden and a corporate office in Göteborg.  www.diaverum.com

About Us

Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD), enabling them to live fulfilling lives. Diaverum is a leading global provider in renal care services and the largest independent provider in Europe, and we help some 39,000 patients with 6 million treatments annually. Our focus is haemodialysis, but we offer a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to coordination of patients’ comorbidities and transplantation services. CKD is a global and escalating challenge today affecting about 10% of the world’s adult population. It’s primarily caused by lifestyle diseases such as diabetes, and the prevalence is increasing in particular in developing countries. CKD disproportionately affects low income individuals and we ensure that our clinics are a safe and familiar space where all our patients are made to feel welcome. Diaverum’s vision is to transform renal care, to offer the highest quality of care and empower patients to live a fulfilling life. We work together with payers to reduce total cost of care while partnering with local communities to educate around health and the value of prevention. At the centre of what we do is our standardised, proprietary care delivery model, enabled by a continuously evolving digital infrastructure. We strive to ensure superior medical outcomes exceeding those demanded by national healthcare systems and we support patients by improving personalized care, ease of use and new services through technology. Diaverum employs more than 11,000 employees and operates more than 420 clinics in 22 countries globally. Diaverum has its head office in Malmö, Sweden. http://www.diaverum.com/